Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2009
09/01/2009US7582259 Chip-shaped blood analysis device constituted by micro trench channels formed in an insulating substrate such as a quartz plate or a polymer resin plate; quick diagnosis of presence of an infectious disease (hepatitis, acquired immune deficiency syndrome, etc.) of the person being tested
09/01/2009US7582196 Housing, first and second gas diffusing electrodes spaced from one another, fuel-cell spacer having acidic electrolyte disposed between electrodes, two gas permeable membranes, first comprises polymer laminated on metal substrate, having pores having dimensions less than one-half thickness of film
09/01/2009US7582099 Method and apparatus for penetrating tissue
09/01/2009US7582063 Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
09/01/2009US7581480 Distributed ground-based threat detection system
09/01/2009US7581457 Method and apparatus for testing materials
09/01/2009US7581425 Gas sensor calibration system
09/01/2009CA2466008C In situ method for determining soil liquefaction tendency and its prevention by electro-osmosis
09/01/2009CA2465800C Instrument
09/01/2009CA2454728C Method and apparatus for testing aldehyde in a polyester polymer
09/01/2009CA2412121C Method for the detection of influenza a/b viruses
09/01/2009CA2407346C Blood components separator disk
09/01/2009CA2381400C Hydrogen sensor
09/01/2009CA2294514C Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
09/01/2009CA2281491C Zcytor7 cytokine receptor
09/01/2009CA2087614C Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction
08/2009
08/29/2009CA2621155A1 Stem cell expression cassettes
08/28/2009CA2623328A1 Mammalian disease detection system
08/27/2009WO2009105757A2 Methods and compositions for diagnosis of age-related macular degeneration
08/27/2009WO2009105670A2 Substrates for multiplexed assays and uses thereof
08/27/2009WO2009105662A1 Methods and systems for treating cell proliferation disorders using plasmonics enhanced photospectral therapy (pepst) and exciton-plasmon enhanced phototherapy (epep)
08/27/2009WO2009105657A1 Compositions and methods for catalyzing dna-programmed chemistry
08/27/2009WO2009105596A2 Tissue sample preprocessing methods and devices
08/27/2009WO2009105591A2 Methods and systems for genome-scale kinetic modeling
08/27/2009WO2009105584A1 Microparticle compositions to modify cancer promoting cells
08/27/2009WO2009105562A2 Protein microarrays for mass spectrometry and methods of use therefor
08/27/2009WO2009105545A1 Methods for screening for agents that affect development
08/27/2009WO2009105537A2 Non-invasive optical characterization of biomaterial mineralization
08/27/2009WO2009105531A1 Methods for cell genotyping
08/27/2009WO2009105520A2 Methods, devices, and compositions for the highly-sensitive detection and identification of diverse molecular entities
08/27/2009WO2009105481A1 Mao-b elevation as an early parkinson's disease biomarker
08/27/2009WO2009105422A2 Detection system for detecting and measuring metal ions in an aqueous medium
08/27/2009WO2009105335A1 Methods and compositions for the diagnosis and treatment of acute lymphoblastic leukemia
08/27/2009WO2009105275A2 Human biomarkers for determining intrinsic b-cell defects
08/27/2009WO2009105264A1 Method for early determination of recurrence after therapy for prostate cancer
08/27/2009WO2009105082A1 Affinity control of tagging noise
08/27/2009WO2009104890A2 Polymicrobial detection device using quantum dot nanocrystal complexes and a detection method therefor
08/27/2009WO2009104836A1 A glucose sensor comprising glucose oxidase variant
08/27/2009WO2009104738A1 Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier
08/27/2009WO2009104714A1 Early genetic test method for cancer
08/27/2009WO2009104698A1 Cholesterol oxidase, chromobacterium sp. microbes, measurement reagent, testing method, gene coding for cholesterol oxidase, recombination vector, transformants, and cholesterol oxidase manufacturing method
08/27/2009WO2009104598A1 Platelet measurement reagent, platelet measurement reagent kit, and platelet measurement method
08/27/2009WO2009104388A1 Prophylactic/therapeutic agent for collagenosis
08/27/2009WO2009104369A1 Method of detecting component contained in plasma and reagent and detection device to be used therein
08/27/2009WO2009104180A1 Nitrogen oxide sensitive field effect transistors for explosive detection comprising functionalized non-oxidized silicon nanowires
08/27/2009WO2009104176A2 Methods of attaching a molecule-of-interest to a microtube
08/27/2009WO2009104174A2 A method of attaching a cell-of-interest to a microtube
08/27/2009WO2009104056A1 Biochip for electrophysiological measurements
08/27/2009WO2009104013A1 Covalently linked thermostable kinase for decontamination process validation
08/27/2009WO2009104001A2 Oligopeptidic compounds and uses thereof
08/27/2009WO2009103988A1 Assay method for antibodies against cyclic citrullinated peptide
08/27/2009WO2009103985A1 Method and kit
08/27/2009WO2009103984A1 Cancer detection methods and techniques
08/27/2009WO2009103862A2 Method for detecting mitotic cells
08/27/2009WO2009103860A1 Biosensor and a related manufacturing method
08/27/2009WO2009103843A2 Method and device for detection of an analyte
08/27/2009WO2009103838A1 Detection and quantification of cyclic imines, based on competitive binding to nicotinic acetylcholine receptors
08/27/2009WO2009103828A1 Improved analytical method for the detection of latent hepatitis c, use thereof and corresponding diagnosis kit
08/27/2009WO2009103826A1 System for producing multimeric peptides and proteins and use thereof
08/27/2009WO2009103791A1 Methods for assissing the risk of adverse events upon treatment with igg4 antibodies
08/27/2009WO2009103784A1 BRCA1 mRNA EXPRESSION LEVELS PREDICT SURVIVAL IN BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY
08/27/2009WO2009103781A1 Method for the prognosis of non-small cell lung cancer
08/27/2009WO2009103779A1 BRCA1 mRNA EXPRESSION PREDICTS SURVIVAL IN PATIENTS WITH BLADDER CANCER TREATED WITH NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPY
08/27/2009WO2009103753A1 Methods for identifying and/or sorting cells by secreted molecule and kits for performing such methods
08/27/2009WO2009103741A2 Use of fsh receptor ligands for diagnosis and therapy of cancer
08/27/2009WO2009103640A1 Method of monitoring the contamination of barrels
08/27/2009WO2009103555A2 Mucosal membrane receptor and uses thereof
08/27/2009WO2009103542A1 Small cell lung carcinoma biomarker panel
08/27/2009WO2009103493A1 Sgk1 as a therapeutic and diagnostic target for viral diseases
08/27/2009WO2009103339A1 Biosensor and a related manufacturing method
08/27/2009WO2009103319A2 Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases
08/27/2009WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
08/27/2009WO2009103295A1 An analysis apparatus for in-line monitoring of fluid
08/27/2009WO2009103243A1 CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS POLYMERASE PAc-PB1n COMPLEX AND USES THEREOF
08/27/2009WO2009103197A1 A sensor for measuring the amount of an analyte in human tissue fluid, a fluid channel unit and a detecting method thereof
08/27/2009WO2009103157A1 Mfap4 as a marker for regulatory cells and anti-cancer cells
08/27/2009WO2009103128A1 Detection of anti-parasitic compounds
08/27/2009WO2009103116A1 Ex vivo cell stimulation
08/27/2009WO2009103115A1 Evaluating the therapeutic potential of a glucan
08/27/2009WO2009103110A1 Cell processing and/or enrichment methods
08/27/2009WO2009086356A3 Method and compositions for specifically detecting physiologically acceptable polymer molecules
08/27/2009WO2009085357A3 Microorganism concentration process
08/27/2009WO2009085237A3 Methods and compositions for identifying lung cancer or a humoral immune response against lung cancer
08/27/2009WO2009084960A3 Methylation detection in the genomic region of a receptor proteintyrosine phosphatase gamma gene for detection and/or diagnosis of a tumour
08/27/2009WO2009080981A3 Method for screening for agents that modulate the activity of the mdm2 ubiquitin ligase and means for implementing said method
08/27/2009WO2009079366A3 System and method for assessing efficacy of therapeutic agents
08/27/2009WO2009075883A3 Glycoprotein cancer biomarker
08/27/2009WO2009073478A3 Tle3 as a marker for chemotherapy
08/27/2009WO2009073412A3 Methods of cleaning wellbores and analyzing wellbore fluids
08/27/2009WO2009071860A3 G immunoglobulin used against anthrax toxins
08/27/2009WO2009069942A3 The rapid diagnostic kits for the detection of antibodies against paragonimus westermani and monoclonal antibodies for production of paragonimus westermani-specific antigens
08/27/2009WO2009064789A3 Methods for detecting and monitoring circulating cancer stem cells
08/27/2009WO2009061904A3 MASS SPECTROMETRY ASSAY FOR eIF4E AND eIF4E REGULON ACTIVITY
08/27/2009WO2009052501A3 Method and apparatus for identifying and tracking biological fluid
08/27/2009WO2009052487A3 Method of detecting oncogenesis of hematopoietic cells
08/27/2009WO2009017914A3 Wetted wall cyclone system and methods
08/27/2009WO2009016432A3 Screening for vase-life and for resistance to xanthomonas in anthurium
08/27/2009WO2008084402A8 Diagnosis and treatment of alzheimer's and other neurodementing diseases
08/27/2009WO2008082987A8 Analyte meter protectors and methods
08/27/2009WO2007084187A3 Molecular cardiotoxicology modeling